Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with a focus on misleading statements regarding the company's financial health and ability to manage macroeconomic challenges during the specified class period from January 30, 2025, to July 23, 2025 [1][4]. Group 1: Allegations and Financial Performance - The lawsuit claims that Dow overstated its ability to handle macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [4]. - It is alleged that the true impact of competitive pressures, declining global sales, and product oversupply on Dow's business was understated [4]. - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, which led to a stock price drop of over 3% [5]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline [6]. - Following the disappointing Q2 results, Dow's stock price fell by more than 17%, and the company announced a dividend cut from $0.70 to $0.35 per share [6]. Group 2: Legal Process and Representation - Investors who purchased Dow securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to represent the interests of all class members [7]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [7]. Group 3: About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8]. - The firm has been recognized for obtaining significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [9].

SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, inclusive (the "Class Period"), have until Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow class action lawsuit. Captioned Sarti v. Dow Inc., No. 25-cv-12744 (E.D. Mich.), the Dow class action lawsuit charges Dow, The Dow Chemical Company, a Dow subsidiary, and certain of Dow's executives wi ...

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, inclusive (the “Class Period”), have until Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow class action lawsuit. Captioned Sarti v. Dow Inc., No. 25-cv-12744 (E.D. Mich.), the Dow class action lawsuit charges Dow, The Dow Chemical Company, a Dow subsidiary, and certain of ...

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with a focus on misleading statements regarding the company's financial health and ability to manage macroeconomic challenges [1][4]. Company Overview - Dow Inc. provides materials science solutions across various sectors, including packaging, infrastructure, mobility, and consumer applications [3]. Allegations of the Lawsuit - The lawsuit claims that Dow and its executives made false or misleading statements about the company's financial flexibility and ability to handle macroeconomic and tariff-related challenges [4]. - It is alleged that Dow understated the negative impacts of competitive pressures, softening global sales, and product oversupply on its business [4]. Financial Performance - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00 due to ongoing weakness in key markets [5]. - Following this downgrade, Dow's stock price fell by over 3% [5]. - On July 24, 2025, Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of approximately $0.17 to $0.18 per share, with net sales of $10.1 billion, a 7.3% year-over-year decline [6]. - Dow's CEO attributed the disappointing results to a challenging earnings environment and announced a dividend cut from $0.70 to $0.35 per share, leading to a stock price drop of over 17% [6]. Legal Process - Investors who purchased Dow securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to represent the interests of all class members [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with claims that the company misrepresented its financial health and ability to manage macroeconomic challenges during a specified class period [1][3]. Summary by Sections Class Action Lawsuit Details - The lawsuit, titled Sarti v. Dow Inc., allows purchasers of Dow securities from January 30, 2025, to July 23, 2025, to seek lead plaintiff status by October 28, 2025 [1]. - The allegations include that Dow overstated its ability to handle macroeconomic and tariff-related challenges and understated the negative impacts on its business [3]. Financial Performance and Market Reactions - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, citing ongoing weakness in key markets [4]. - Following this downgrade, Dow's stock price fell by over 3% [4]. - On July 24, 2025, Dow reported a non-GAAP loss per share of $0.42, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline [5]. - Dow's CEO attributed the disappointing results to a challenging earnings environment and announced a dividend cut from $0.70 to $0.35 per share, leading to a stock price drop of over 17% [5]. Legal Process for Lead Plaintiff - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Dow securities during the class period to seek lead plaintiff status, which involves directing the lawsuit on behalf of all class members [6]. About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7].

Core Viewpoint - The law firm Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with a focus on misleading statements regarding the company's financial health and ability to manage macroeconomic challenges during the specified class period from January 30, 2025, to July 23, 2025 [1][4]. Group 1: Allegations and Financial Performance - The lawsuit claims that Dow overstated its ability to handle macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [4]. - It is alleged that Dow's business faced significant negative impacts from competitive pressures, declining global sales, and an oversupply of products [4]. - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, which led to a stock price drop of over 3% [5]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline [6]. - Following the disappointing earnings report, Dow's stock price fell by more than 17% after announcing a dividend cut from $0.70 to $0.35 per share [6]. Group 2: Class Action Process - Investors who purchased Dow securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to act on behalf of all class members [7]. - The lead plaintiff can choose a law firm to represent the class, and participation as lead plaintiff does not affect the ability to share in any potential recovery [7]. Group 3: About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8]. - The firm has been recognized for obtaining significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [9].

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, focusing on misleading statements regarding the company's financial health and the impact of macroeconomic factors on its performance [1][3]. Summary by Sections Class Action Lawsuit Details - The lawsuit, titled Sarti v. Dow Inc., allows purchasers of Dow securities between January 30, 2025, and July 23, 2025, to seek lead plaintiff status by October 28, 2025 [1]. - The allegations include that Dow and its executives overstated the company's ability to handle macroeconomic challenges and downplayed the negative impacts on its business [3]. Financial Performance and Market Reaction - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, which led to a stock price drop of over 3% [4]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline, missing estimates by $130 million [5]. - Following the disappointing results, Dow's stock price fell by more than 17%, and the company announced a dividend cut from $0.70 to $0.35 per share due to a challenging macroeconomic environment [5]. Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows investors to seek lead plaintiff status, with the lead plaintiff representing the interests of the class [6]. - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is noted for its significant recoveries in securities fraud cases, having recovered over $2.5 billion for investors in 2024 alone [7][8].

Accessibility StatementSkip Navigation SAN DIEGO, Sept. 17, 2025 /PRNewswire/ --Â Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), have until Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow class action lawsuit. Captioned Sarti v. Dow Inc., No. 25-cv-12744 (E.D. Mich.), the Dow class action lawsuit charges Dow, The Dow Chemical Company, a ...

Core Viewpoint - The Dow class action lawsuit alleges that Dow Inc. and its executives made misleading statements regarding the company's financial health and ability to manage macroeconomic challenges, leading to significant investor losses during the specified class period [3][4][5]. Group 1: Class Action Details - The class action lawsuit is titled Sarti v. Dow Inc., No. 25-cv-12744 (E.D. Mich.), and it involves purchasers of Dow securities from January 30, 2025, to July 23, 2025 [1]. - Investors have until October 28, 2025, to seek appointment as lead plaintiff in the lawsuit [1][6]. - The lawsuit claims that Dow overstated its ability to handle macroeconomic and tariff-related challenges, which negatively impacted its business and financial condition [3]. Group 2: Allegations and Financial Impact - The lawsuit alleges that on June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, which was attributed to ongoing weakness in key markets [4]. - Following this downgrade, Dow's stock price fell by over 3% [4]. - On July 24, 2025, Dow reported a non-GAAP loss per share of $0.42, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline [5]. - Dow's CEO attributed the disappointing results to a challenging earnings environment and announced a dividend cut from $0.70 to $0.35 per share, leading to a stock price drop of over 17% [5]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Dow securities during the class period to seek lead plaintiff status [6]. - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [7][8].

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding the company's financial health and ability to manage macroeconomic challenges [1][3]. Company Allegations - The lawsuit alleges that Dow overstated its ability to handle macroeconomic and tariff-related challenges, and understated the negative impacts of competitive pressures, softening global sales, and product oversupply on its business [3]. - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, citing ongoing weakness in key markets and pressure on dividends [4]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline, missing estimates by $130 million [5]. Financial Impact - Following the downgrade by BMO Capital, Dow's stock price fell by over 3% [4]. - After the Q2 2025 earnings report, Dow's stock price dropped by more than 17%, and the company announced a dividend cut from $0.70 to $0.35 per share to maintain financial flexibility in a challenging environment [5].